The Inquiry - Why drug firms don’t invest more in curing early stage cancer - ÃÛÑ¿´«Ã½ Sounds

The Inquiry - Why drug firms don’t invest more in curing early stage cancer - ÃÛÑ¿´«Ã½ Sounds
Why drug firms don’t invest more in curing early stage cancer
MIT Economics Professor Heidi Williams studied the treatments that got the most funding.